Journey Medical Statistics
Total Valuation
DERM has a market cap or net worth of $70.25 million. The enterprise value is $63.96 million.
| Market Cap | 70.25M |
| Enterprise Value | 63.96M |
Important Dates
The last earnings date was Monday, May 13, 2024, after market close.
| Earnings Date | May 13, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
DERM has 20.01 million shares outstanding. The number of shares has increased by 10.95% in one year.
| Shares Outstanding | 20.01M |
| Shares Change (YoY) | +10.95% |
| Shares Change (QoQ) | +5.69% |
| Owned by Insiders (%) | 31.99% |
| Owned by Institutions (%) | 13.16% |
| Float | 8.27M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 0.88 |
| Forward PS | 1.19 |
| PB Ratio | 5.42 |
| P/FCF Ratio | 59.68 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 50.84, with an EV/FCF ratio of 54.34.
| EV / Earnings | n/a |
| EV / Sales | 0.80 |
| EV / EBITDA | 50.84 |
| EV / EBIT | n/a |
| EV / FCF | 54.34 |
Financial Position
The company has a current ratio of 1.21, with a Debt / Equity ratio of 1.37.
| Current Ratio | 1.21 |
| Quick Ratio | 0.87 |
| Debt / Equity | 1.37 |
| Debt / EBITDA | 14.12 |
| Debt / FCF | 15.10 |
| Interest Coverage | -1.47 |
Financial Efficiency
Return on equity (ROE) is -32.80% and return on invested capital (ROIC) is -8.47%.
| Return on Equity (ROE) | -32.80% |
| Return on Assets (ROA) | -6.00% |
| Return on Capital (ROIC) | -8.47% |
| Revenue Per Employee | $1.95M |
| Profits Per Employee | -$101,439 |
| Employee Count | 41 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 2.27 |
Taxes
In the past 12 months, DERM has paid $221,000 in taxes.
| Income Tax | 221,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +178.23% in the last 52 weeks. The beta is 0.78, so DERM's price volatility has been lower than the market average.
| Beta (1Y) | 0.78 |
| 52-Week Price Change | +178.23% |
| 50-Day Moving Average | 3.64 |
| 200-Day Moving Average | 3.86 |
| Relative Strength Index (RSI) | 45.05 |
| Average Volume (30 Days) | 142,466 |
Short Selling Information
The latest short interest is 283,293, so 1.42% of the outstanding shares have been sold short.
| Short Interest | 283,293 |
| Short Previous Month | 235,520 |
| Short % of Shares Out | 1.42% |
| Short % of Float | 3.42% |
| Short Ratio (days to cover) | 1.70 |
Income Statement
In the last 12 months, DERM had revenue of $80.00 million and -$4.16 million in losses. Loss per share was -$0.31.
| Revenue | 80.00M |
| Gross Profit | 52.97M |
| Operating Income | -2.60M |
| Pretax Income | -3.94M |
| Net Income | -4.16M |
| EBITDA | 1.26M |
| EBIT | -2.34M |
| Loss Per Share | -$0.31 |
Balance Sheet
The company has $24.06 million in cash and $17.77 million in debt, giving a net cash position of $6.29 million or $0.31 per share.
| Cash & Cash Equivalents | 24.06M |
| Total Debt | 17.77M |
| Net Cash | 6.29M |
| Net Cash Per Share | $0.31 |
| Equity / Book Value | 12.95M |
| Book Value Per Share | 0.65 |
| Working Capital | 8.08M |
Cash Flow
| Operating Cash Flow | 1.18M |
| Capital Expenditures | n/a |
| Free Cash Flow | 1.18M |
| FCF Per Share | $0.06 |
Margins
Gross margin is 66.22%, with operating and profit margins of -3.25% and -5.20%.
| Gross Margin | 66.22% |
| Operating Margin | -3.25% |
| Pretax Margin | -4.92% |
| Profit Margin | -5.20% |
| EBITDA Margin | 1.57% |
| EBIT Margin | -2.93% |
| FCF Margin | 1.47% |
Dividends & Yields
DERM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.95% |
| Shareholder Yield | -10.95% |
| Earnings Yield | -5.92% |
| FCF Yield | 1.68% |
Analyst Forecast
The average price target for DERM is $7.25, which is 110.15% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.25 |
| Price Target Difference | 110.15% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
DERM has an Altman Z-Score of 0.28 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.28 |
| Piotroski F-Score | 5 |